Vendor review
Orbitrex Peptides is graded A- (85/100). It passed the trust floor (a score of at least 70 with testing, transparency and catalog data all observed), so its offers can be picks. We track 36 offers from Orbitrex Peptides. Prices last checked Nov 14, 2026.
Prices checked · Picks as of · Grade evidence cutoff
Price position
Cheaper than the median on 19 of 35 products that other tracked vendors also sell; above it on 12 and at it on 4. 1 other product has no other tracked offer. Prices are effective single-package prices; the median covers every tracked offer for the same product.
| Product | Orbitrex Peptides price | Median of tracked offers | Position | Pick |
|---|---|---|---|---|
| Adamax 10 mg vial | $69.99 | $69.9911 offers | At the median | |
| AOD-9604 5 mg vial | $59.99out of stock when checked | $4525 offers | 33% above the median | |
| BPC-157 10 mg vial | $39.99 | $49.9929 offers | 20% below the median | |
| Cagrilintide 10 mg vial | $89.99 | $89.9921 offers | At the median | |
| Cartalax 20 mg vial | $59.99 | $59.9919 offers | At the median | |
| Cortagen 20 mg vial | $59.99 | $597 offers | 2% above the median | |
| DSIP 10 mg vial | $39.99 | $4516 offers | 11% below the median | |
| FOXO4-DRI 10 mg vial | $199.99 | $13018 offers | 54% above the median | |
| Glutathione 1500 mg vial | $59.99out of stock when checked | $6521 offers | 8% below the median | |
| Ipamorelin 10 mg vial | $49.99 | $5030 offers | Just below the median | |
| LL-37 5 mg vial | $44.99 | $6013 offers | 25% below the median | |
| MOTS-c 10 mg vial | $39.99 | $4828 offers | 17% below the median | |
| MOTS-c 40 mg vial | $99.99out of stock when checked | $90.5012 offers | 10% above the median | |
| NAD+ 500 mg vial | $59.99 | $62.4930 offers | 4% below the median | |
| Oxytocin 2 mg vial | $29.99out of stock when checked | $32.496 offers | 8% below the median | |
| Retatrutide 10 mg vial | $69.99 | $69.5010 offers | 1% above the median | |
| Retatrutide 20 mg vial | $119.99 | $104.998 offers | 14% above the median | |
| Selank 10 mg vial | $29.99 | $40.9034 offers | 27% below the median | |
| Selank 30 mg vial | $79.99out of stock when checked | None1 offer | Only tracked offer | |
| Semaglutide 10 mg vial | $39.99 | $63.209 offers | 37% below the median | |
| Semaglutide 20 mg vial | $79.99 | $1155 offers | 30% below the median | |
| Semax 10 mg vial | $29.99 | $40.4028 offers | 26% below the median | |
| Semax 30 mg vial | $79.99out of stock when checked | $68.506 offers | 17% above the median | |
| Sermorelin 10 mg vial | $59.99 | $64.5022 offers | 7% below the median | |
| SLU-PP-332 5 mg vial | $49.99out of stock when checked | $49.995 offers | At the median | |
| Survodutide 10 mg vial | $99.99 | $955 offers | 5% above the median | |
| TB-500 10 mg vial | $49.99 | $5534 offers | 9% below the median | |
| Tesamorelin 10 mg vial | $69.99 | $6527 offers | 8% above the median | |
| Thymosin Alpha-1 10 mg vial | $69.99out of stock when checked | $6530 offers | 8% above the median | |
| Tirzepatide 10 mg vial | $49.99 | $66.508 offers | 25% below the median | |
| Tirzepatide 15 mg vial | $59.99 | $51.504 offers | 16% above the median | |
| Tirzepatide 30 mg vial | $109.99 | $141.999 offers | 23% below the median | |
| Tirzepatide 60 mg vial | $169.99 | $203.998 offers | 17% below the median | |
| Vilon 20 mg vial | $49.99out of stock when checked | $605 offers | 17% below the median | |
| VIP (Vasoactive Intestinal Peptide) 10 mg vial | $79.99 | $5914 offers | 36% above the median | |
| Wolverine Blend (BPC-157/TB-500) 20 mg vial | $79.99 | $84.9915 offers | 6% below the median |
Picks won
No picks as of Nov 14, 2026: none of its offers met every pick rule.
Testing record
Of 36 tracked products: 1 with a lab-verified COA, 1 with a product COA on file and 34 with only COAs for other products. 163 public COAs from Orbitrex Peptides are archived; the newest was tested Jul 28, 2026. Labs named on COAs for its tracked products: Freedom Diagnostics and TrustPointe Analytics.
A COA describes the batch it names. It does not show which lot a vendor ships today, and PepGrades does not ask vendors to say.
Deals
No automatic deal from Orbitrex Peptides is on record.
Transparency checklist
7 of 8 public pages were found when the grade was built (evidence cutoff Sep 12, 2026). A page found is not a review of its terms; shipping fees, delivery times and refund terms are not recorded.
Grade
A- (85/100) from the components below, with evidence up to Sep 12, 2026. Price updates do not change the grade; public discussion is not scored.